Skip to main content
Terug
HIMS logo

Hims & Hers Health, Inc.

Datakwaliteit: 100%
HIMS
NYSE Healthcare Medical - Equipment & Services
€ 19,38
▼ € 1,48 (-7,09%)
Marktkapitalisatie: 4,26B
Dagbereik
€ 19,18 € 20,60
52-Weeksbereik
€ 13,74 € 70,43
Volume
22.245.152
50D / 200D Gem.
€ 23,15 / € 41,39
Vorige Slotkoers
€ 20,86

Quick Summary

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (633 peers)

Metriek Aandeel Sector Mediaan
P/E 33,2 0,2
P/B 7,9 2,8
ROE % 25,2 3,7
Net Margin % 5,5 3,9
Rev Growth 5Y % 71,4 10,0
D/E 2,3 0,2

Koersdoel Analisten

Hold
€ 29,92 +54.4%
Low: € 12,50 High: € 60,00
Forward K/W
49,65
Forward WPA
€ 0,42
WPA Groei (sch.)
+0,0%
Omzet Sch.
2,76B

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2030 € 1,86
€ 1,57 – € 2,20
4,63B 1
FY2029 € 1,38
€ 1,17 – € 1,64
4,73B 1
FY2028 € 1,08
€ 0,85 – € 1,27
3,92B 5

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-23 € 0,02 € 0,07 +250,0%
2025-11-03 € 0,09 € 0,06 -33,3%
2025-08-04 € 0,18 € 0,17 -5,6%
2025-05-05 € 0,12 € 0,20 +65,4%
2025-02-24 € 0,09 € 0,11 +22,2%
2024-11-04 € 0,06 € 0,06 0,0%
2024-08-05 € 0,04 € 0,06 +40,4%
2024-05-06 € 0,01 € 0,05 +316,7%

Dividend History

Yield

0,00%

Payout Ratio

0,00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Belangrijkste Punten

Revenue grew 71,42% annually over 5 years — strong growth
ROE of 25,23% indicates high profitability
Debt/Equity of 2,34 — high leverage
Generating 73,96M in free cash flow
P/E of 33,15 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 12,42%

Groei

Revenue Growth (5Y)
71,42%
Revenue (1Y)59,00%
Earnings (1Y)1,85%
FCF Growth (3Y)25,46%

Kwaliteit

Return on Equity
25,23%
ROIC4,39%
Net Margin5,47%
Op. Margin4,50%

Veiligheid

Debt / Equity
2,34
Current Ratio1,90
Interest Coverage0,00

Waardering

P/E Ratio
33,15
Forward P/E49,65
P/B Ratio7,87
EV/EBITDA50,09
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 59,00% Revenue Growth (3Y) 64,08%
Earnings Growth (1Y) 1,85% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 71,42% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2,35B Net Income (TTM) 128,37M
ROE 25,23% ROA 5,96%
Gross Margin 73,84% Operating Margin 4,50%
Net Margin 5,47% Free Cash Flow (TTM) 73,96M
ROIC 4,39% FCF Growth (3Y) 25,46%
Safety
Debt / Equity 2,34 Current Ratio 1,90
Interest Coverage 0,00
Dividends
Dividend Yield 0,00% Payout Ratio 0,00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 33,15 Forward P/E 49,65
P/B Ratio 7,87 P/S Ratio 1,81
PEG Ratio -33,00 Forward PEG N/A
EV/EBITDA 50,09 Fwd EV/EBITDA 16,85
Forward P/S 1,54 Fwd Earnings Yield 2,01%
FCF Yield 1,74%
Market Cap 4,26B Enterprise Value 5,29B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2,35B 1,48B 872,00M 526,92M 271,88M
Net Income 128,37M 126,04M -23,55M -65,68M -107,66M
EPS (Diluted) 0,51 0,53 -0,11 -0,32 -0,58
Gross Profit 1,73B 1,17B 714,95M 408,72M 204,49M
Operating Income 105,61M 61,90M -29,45M -68,70M -115,04M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,15B 707,54M 441,19M 366,34M 420,59M
Total Liabilities 1,61B 230,82M 97,16M 54,60M 85,97M
Shareholders' Equity 540,93M 476,72M 344,03M 311,74M 334,62M
Total Debt 1,26B 11,35M 9,95M 5,31M 5,48M
Cash & Equivalents 228,62M 220,58M 96,66M 46,77M 71,78M
Current Assets 767,64M 395,83M 265,05M 216,60M 269,91M
Current Liabilities 404,43M 221,37M 88,47M 47,94M 79,22M